Skip to main content

CVE detail

CVE-2026-58300

Absolute path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

CVSS 6.2 · MediumBuzz score 17.5

Buzz score

Why this CVE is surfacing

Buzz score total 17.5

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 11.0 · diversity 6.5 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
11.0
2 evidence mentions in the snapshot
Diversity score
6.5
2 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
2
within the 30d window
Peak daily
1
highest bucket

Evidence

Source links by recency

Newest mentions first
2 source links · newest first
  • The July 2026 Security Update ReviewZero Day Initiative

    oser look at some of the more interesting updates for this month, starting with the bugs being exploited in the wild. - CVE-2026-56155 - Active Directory Federation Services Elevation of Privilege Vulnerability This is one of several AD FS being patched this month, but it’s the only one being actively exploited. It stems from insufficient access-contro

    vendorwww.thezdi.comJul 14, 2026, 5:56 PM
  • Absolute path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

    vendormsrc.microsoft.comJul 3, 2026, 2:00 PM

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence